The “war” on cancer: are we “winning” or “losing” or what?

Clifton Leaf is a cancer survivor. He is also the Editor-in-Chief of Fortune magazine. And he has long argued that we may not be making the most astute decisions about how we are trying to find “the best” and “the rightest” ways to diagnose, treat, and manage cancer. … READ MORE …

Finasteride lowers risk for diagnosis with prostate cancer WITHOUT increased risk for prostate cancer-specific mortality

Something that most of us seem to have managed to “miss” at the American Urological Association (AUA) annual meeting in San Francisco in May was an update from Dr. Ian Thompson on the 25-year outcomes of the Prostate Cancer Prevention Trial (PCPT). It has the potential to be rather important! … READ MORE …

But can exercise lower risk for prostate cancer diagnosis or progression?

In an incidentally timely manner, the May issue of Annals of Oncology carries a systematic review and meta-analysis of data on physical activity and risk for prostate cancer. … READ MORE …

Exercise alone: no evidence that this can lower prostate cancer risk

It should come as no great surprise to anyone that one’s level of physical activity is not necessarily linked, on its own, to one’s risk for diagnosis with prostate cancer. … READ MORE …

OMG … as if it wasn’t bad enough to have the acne in the first place … !

Just in case most of our readers are so old that they have forgotten … severe acne is one of the traumatizing events of male (and female) adolescence. I mean, “Duh. Whose gonna wanna to date me when … READ MORE …

Anticoagulation therapy and prostate cancer prevention

Today’s “hot news story” in the cancer world is that a very widely used drug called warfarin (often still known as Coumadin) may be able to protect people from  the risks of getting diagnosed with at least some cancers. But … READ MORE …

Testosterone replacement therapy and prostate cancer risk

A new article in the Journal of Clinical Oncology has further undermined the long-held belief that there was an inherently increased risk for prostate cancer among men who received treatment with testosterone replacement therapy (TRT) for low testosterone levels. … READ MORE …